A Review of the Challenge in Measuring Hemoglobin A1c
Authors:
Open Access
- 1 May 2009
- journal article
- review article
- Published by SAGE Publications in Journal of Diabetes Science and Technology
- Vol. 3 (3) , 439-445
Abstract
The attraction of the simple biochemical concept combined with a clinical requirement for a long-term marker of glycolic control in diabetes has made hemoglobin A1c (HbA1c) one of the most important assays undertaken in the medical laboratory. The diversity in the biochemistry of glycation, clinical requirements, and management demands has resulted in a broad range of methods being developed since HbA1c was described in the late 1960s. A range of analytic principles are used for the measurement of HbA1c. The charge difference between hemoglobin A0 and HbA1c has been widely utilized to separate these two fractions, most notably found these days in ion-exchange high-performance liquid chromatography systems; the difference in molecular structure (affinity chromatography and immunochemical methods) are becoming widely available. Different results found in different laboratories using a variety of HbA1c analyses resulted in the need for standardization, most notably in the United States, Japan, and Sweden. Designated comparison methods are now located in these three countries, but as they are arbitrarily chosen and have differences in specificity, results of these methods and the reference values and action limits of the methods differ and only harmonized HbA1c in specific geographic areas. A reference measurement system within the concept of metrological traceability is now globally accepted as the only valid analytic anchor. However, there is still discussion over the units to be reported. The consensus statement of the International Federation of Clinical Chemistry (IFCC), the American Diabetes Association, the International Diabetes Federation, and the European Association for the Study of Diabetes suggests reporting HbA1c in IFCC units (mmol/mol), National Glycohemoglobin Standardization Program units (%), and estimated average glucose (either in mg/dl or mmol/liter). The implementation of this consensus statement raised new questions, to be answered in a concerted action of clinicians, biochemists, external quality assessment organizers, patient groups, and manufacturers.Keywords
This publication has 30 references indexed in Scilit:
- Haemoglobin A 1c analysis in the management of patients with diabetes: from chaos to harmony: Table 1Journal of Clinical Pathology, 2008
- Translating the A1C Assay Into Estimated Average Glucose ValuesDiabetes Care, 2008
- The IFCC Reference Measurement System for HbA1c: A 6-Year Progress ReportClinical Chemistry, 2008
- The relationship between mean glucose and HbA1c in premenopausal women compared with males in the Diabetes Control and Complications TrialDiabetic Medicine, 2008
- Effects of Hemoglobin C and S Traits on Glycohemoglobin Measurements by Eleven MethodsClinical Chemistry, 2005
- The biosynthesis of human hemoglobin A1c. Slow glycosylation of hemoglobin in vivo.Journal of Clinical Investigation, 1976
- Studies of an unusual hemoglobin in patients with diabetes mellitusBiochemical and Biophysical Research Communications, 1969
- Observations on the Chromatographic Heterogeneity of Normal Adult and Fetal Human Hemoglobin: A Study of the Effects of Crystallization and Chromatography on the Heterogeneity and Isoleucine ContentJournal of the American Chemical Society, 1958
- New Hemoglobin in Normal Adult BloodScience, 1955
- Sickle Cell Anemia, a Molecular DiseaseScience, 1949